1229 related articles for article (PubMed ID: 31557902)
21. Bile acid: a potential inducer of colon cancer stem cells.
Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
[TBL] [Abstract][Full Text] [Related]
22. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.
Zare M; Bastami M; Solali S; Alivand MR
J Cell Physiol; 2018 May; 233(5):3729-3744. PubMed ID: 28771724
[TBL] [Abstract][Full Text] [Related]
23. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy.
Khan AQ; Hasan A; Mir SS; Rashid K; Uddin S; Steinhoff M
Semin Cancer Biol; 2024 May; 100():1-16. PubMed ID: 38503384
[TBL] [Abstract][Full Text] [Related]
24. Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation.
Krzysiek-Maczka G; Targosz A; Szczyrk U; Strzalka M; Brzozowski T; Ptak-Belowska A
J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 31889044
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
26. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
[No Abstract] [Full Text] [Related]
27. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
28. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-to-mesenchymal transition in tumor progression.
Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
[TBL] [Abstract][Full Text] [Related]
30. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.
Serrano-Gomez SJ; Maziveyi M; Alahari SK
Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733
[TBL] [Abstract][Full Text] [Related]
31. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
Kaller M; Hermeking H
Adv Exp Med Biol; 2016; 937():71-92. PubMed ID: 27573895
[TBL] [Abstract][Full Text] [Related]
32. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
33. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
34. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition.
Katsuno Y; Meyer DS; Zhang Z; Shokat KM; Akhurst RJ; Miyazono K; Derynck R
Sci Signal; 2019 Feb; 12(570):. PubMed ID: 30808819
[TBL] [Abstract][Full Text] [Related]
35. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds.
Ang HL; Mohan CD; Shanmugam MK; Leong HC; Makvandi P; Rangappa KS; Bishayee A; Kumar AP; Sethi G
Med Res Rev; 2023 Jul; 43(4):1141-1200. PubMed ID: 36929669
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer.
Bedi U; Mishra VK; Wasilewski D; Scheel C; Johnsen SA
Oncotarget; 2014 Apr; 5(8):2016-29. PubMed ID: 24840099
[TBL] [Abstract][Full Text] [Related]
38. Landscape perspectives of tumor, EMT, and development.
Yu C; Liu Q; Chen C; Yu J; Wang J
Phys Biol; 2019 Jul; 16(5):051003. PubMed ID: 31067516
[TBL] [Abstract][Full Text] [Related]
39. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
[TBL] [Abstract][Full Text] [Related]
40. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]